A reinvented AI global solutions company appears to be making progress with its costly pivot. It’s still early days, but there are encouraging signs with a 9% dividend yield to encourage interest. Elsewhere, we look at several other unloved recovery stories, although the future of one company looks particularly doubtful to us. Read on here for our usual forthright views.
TPXImpact: shares rise on big contract win Shares in TPXimpact (AIM: TPX), the technology-enabled services company, climbed on news that it has been selected as the successful bidder for a £22m, 2-year digital transformation award with NHS England. The award forms part of NHS England's Digital Prevention Services Portfolio, established to design, build and operate digital and data services that support the prevention of ill health and early intervention. Under the award, TPXimpact’s work will primarily support healthcare professionals responsible for administering, recording and managing vaccinations through digital systems, including GPs, nurses, midwives, pharmacists, School Aged Immunisation Service teams and…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login